fda warning compounding semaglutide september 2025 issued 25 letters to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of FDA Drug Recalls and Warnings:

TB-500 nerve-recovery evidence rating Emerging preclinical evidence The findings are intriguing, but human neurological applications require significantly more research

Pennsylvania was among 16 states that covered GLP-1s for obesity treatment last year, according to KFFs Medicaid budget survey in October

Reintroduce normal foods gradually once your symptoms improve, typically after 8-12 weeks

Conclusion GLP-1 can change weight, but it doesnt always shape a body that feels good or looks strong

Am J Med Genet 1995

GLP-1 receptor agonists act wherever there are relevant receptors: in the pancreas, stomach, brain, kidneys, and blood vessels